Lin MY - Search Results

1

Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccine.

Lin YJ, Lin MY, Chuang YS, Liu LT, Kuo TY, Chen C, Ganesan S, Fattom A, Bitko V, Lien CE. Lin YJ, et al. Among authors: lin my. Sci Rep. 2022 Jul 5;12(1):11369. doi: 10.1038/s41598-022-15238-y. Sci Rep. 2022. PMID: 35790783 Free PMC article.

2

Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19.

Kuo TY, Lin MY, Coffman RL, Campbell JD, Traquina P, Lin YJ, Liu LT, Cheng J, Wu YC, Wu CC, Tang WH, Huang CG, Tsao KC, Chen C. Kuo TY, et al. Among authors: lin yj, lin my. Sci Rep. 2020 Nov 18;10(1):20085. doi: 10.1038/s41598-020-77077-z. Sci Rep. 2020. PMID: 33208827 Free PMC article.

3

CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge.

Lien CE, Lin YJ, Chen C, Lian WC, Kuo TY, Campbell JD, Traquina P, Lin MY, Liu LT, Chuang YS, Ko HY, Liao CC, Chen YH, Jan JT, Ma HH, Sun CP, Lin YS, Wu PY, Wang YC, Tao MH, Lin YL. Lien CE, et al. Among authors: lin yj, lin yl, lin ys, lin my. Sci Rep. 2021 Apr 22;11(1):8761. doi: 10.1038/s41598-021-88283-8. Sci Rep. 2021. PMID: 33888840 Free PMC article.

4

Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.

Lien CE, Kuo TY, Lin YJ, Lian WC, Lin MY, Liu LT, Cheng J, Chou YC, Chen C. Lien CE, et al. Among authors: lin yj, lin my. Clin Infect Dis. 2022 Jun 10;74(11):1899-1905. doi: 10.1093/cid/ciab711. Clin Infect Dis. 2022. PMID: 34739037 Free PMC article.

5

Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2.

Huang KA, Zhou D, Tan TK, Chen C, Duyvesteyn HME, Zhao Y, Ginn HM, Qin L, Rijal P, Schimanski L, Donat R, Harding A, Gilbert-Jaramillo J, James W, Tree JA, Buttigieg K, Carroll M, Charlton S, Lien CE, Lin MY, Chen CP, Cheng SH, Chen X, Lin TY, Fry EE, Ren J, Ma C, Townsend AR, Stuart DI. Huang KA, et al. Among authors: lin ty, lin my. Theranostics. 2022 Jan 1;12(1):1-17. doi: 10.7150/thno.65563. eCollection 2022. Theranostics. 2022. PMID: 34987630 Free PMC article.

6

Hamsters Protected from SARS-CoV-2 Delta Variant Challenge after Two Doses of Adjuvanted SARS-CoV-2 Recombinant Spike Protein (S-2P) and One Dose of Beta S-2P.

Kuo TY, Lien CE, Lin YJ, Lin MY, Wu CC, Tang WH, Campbell JD, Traquina P, Chuang YS, Liu LT, Cheng J, Chen C. Kuo TY, et al. Among authors: lin yj, lin my. J Infect Dis. 2022 Nov 1;226(9):1562-1567. doi: 10.1093/infdis/jiac153. J Infect Dis. 2022. PMID: 35451470 Free PMC article.

7

Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice.

Ganesan S, Acosta H, Brigolin C, Orange K, Trabbic K, Chen C, Lien CE, Lin YJ, Lin MY, Chuang YS, Fattom A, Bitko V. Ganesan S, et al. Among authors: lin yj, lin my. PLoS One. 2022 Nov 2;17(11):e0272594. doi: 10.1371/journal.pone.0272594. eCollection 2022. PLoS One. 2022. PMID: 36322572 Free PMC article.

8

An evaluation of the safety and immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III, parallel group, randomized, double-blind, active-controlled immunobridging study in Paraguay.

Torales J, Cuenca-Torres O, Barrios L, Armoa-Garcia L, Estigarribia G, Sanabria G, Lin MY, Antonio Estrada J, Estephan L, Cheng HY, Chen C, Janssen R, Lien CE. Torales J, et al. Among authors: lin my. Vaccine. 2023 Jan 4;41(1):109-118. doi: 10.1016/j.vaccine.2022.10.030. Epub 2022 Nov 18. Vaccine. 2023. PMID: 36404171 Free PMC article. Clinical Trial.

9

Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: a randomized phase 2 trial.

Liu LT, Chiu CH, Chiu NC, Tan BF, Lin CY, Cheng HY, Lin MY, Lien CE, Chen C, Huang LM. Liu LT, et al. Among authors: lin cy, lin my. NPJ Vaccines. 2022 Dec 16;7(1):165. doi: 10.1038/s41541-022-00589-4. NPJ Vaccines. 2022. PMID: 36526640 Free PMC article.

10

Clinical Trial: Precise Administration of Sucralfate Powder in Prevention of Delayed Postpolypectomy Bleeding. A Randomized Controlled Trial.

Chiang HC, Chen PJ, Yang EH, Kuo TL, Hsieh MT, Kang JW, Cheng HC, Chang WL, Chen WY, Chiu HC, Lin MY, Hong TC, Chiang CM, Chen WC, Huang KK, Lu MH, Wu MH, Chen CY, Lin XZ, Chuang CH. Chiang HC, et al. Among authors: lin my. Clin Transl Gastroenterol. 2025 Jan 21. doi: 10.14309/ctg.0000000000000818. Online ahead of print. Clin Transl Gastroenterol. 2025. PMID: 39836033

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

853 results

Search Page

Filters